NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









InSphero

InSphero

Private
SchlierenHealthcare & Life Scienceshttps://insphero.com/

Last Round

Series D

Mar 31, 2023

Total Funding Raised

$26.49M

Company Overview

InSphero is a biotechnology company that develops and provides 3D cell-based assay and organ-on-a-chip technology designed to deliver biologically relevant insights for in vitro testing.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

3D microtissuesorgan-on-a-chipOOCcontract research organizationCROorganoidsspheroidspreclinical testingdrug discovery servicesnew approach methodologiesNAMssafety testingin-vitro modelstoxicology servicestox testingphenotypic screeningliver modelsoncology modelsAI-assisted analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InSphero Comparables

Compare InSphero with similar companies based on industry and business-model similarity.

InSphero comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MIMETAS
88%
Emulate
86%
CN Bio
85%

InSphero Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMar 31, 2023
GrantJan 23, 2023
VC RoundJun 13, 2018
Series CJul 8, 2015
Series BJun 18, 2013
Series A
Aug 5, 2010

Key People

Founding team and executive leadership

Jan Lichtenberg

Chief Executive Officer And Board Member

Executive Team

InSphero Investors

Notable investors and investment history

InSphero investors
InvestorRounds
Eurostars SME programmeGrant
InnosuisseGrant
RedalpineVC Round, Series A
BpifranceGrant
OCCIDENTSeries D
Zurcher KantonalbankVC Round, Series A
ZEISS VenturesSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors grew 54% MoM.

  • Mar 31, 2023

    ZEISS Ventures led the Series D round.

InSphero Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

InSphero Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InSphero's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren
Employee Range81
Year Founded2009
Last FundingMar 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.